US Business

A potential deal could value the Japanese company at around $30 billion as a scramble for memory chips used in smartphones and other devices heats up.

Johnson & Johnson says the batch didn’t advance to the filling and finish stages of its manufacturing process and that the quality lapse wouldn’t affect its ability to supply the U.S. with 100 million doses by the end of May.

The funds, which would be raised by tax increases, would go toward production incentives and research and design, including the creation of a National Semiconductor Technology Center.

Ericsson CEO Börje Ekholm felt moved to lobby for Chinese rival Huawei to protect his global business against a backlash from Beijing. His biggest shareholder, Sweden’s Wallenberg family, also felt the heat.

With ships moving again through the Suez Canal, another bottleneck in the supply chain remains—this one in Southern California, where the ports of Los Angeles and Long Beach together handle more than a third of U.S. container imports.

The Federal Trade Commission said it would seek to block Illumina’s planned $7.1 billion acquisition of a developer of a long-sought blood test that promises to detect cancer early.

The car maker is not swapping a ‘k’ for a ‘t’ to rename its U.S. subsidiary “Voltswagen of America” as an earlier press release had indicated, the company said, calling the announcement an April Fools’ joke.

Companies are scrambling to secure port berths and scarce containers, as logistics are upended.

The ratings gap between the major players is tighter than in the year-end quarter, as the networks try to establish their approach at the outset of the Biden administration.

If proven to work safely, the version to undergo a clinical trial would make handling the shots easier in rural areas and low-income countries.